Average Co-Inventor Count = 3.19
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Warner-lambert Company (143 from 2,538 patents)
2. Other (4 from 832,891 patents)
3. Millennium Pharmaceuticals Limited (4 from 850 patents)
4. David T. Connor (0 patent)
5. Daniel L. Flynn (0 patent)
6. Paul C. Unangst (0 patent)
7. Michael W. Wilson (0 patent)
8. Gary P. Shrum (0 patent)
9. Catherine R. Kostlan (0 patent)
10. Michael D. Mullican (0 patent)
150 patents:
1. 7214712 - Isophthalic acid derivatives as matrix metalloproteinase inhibitors
2. 7067538 - MCP-1 receptor antagonists and methods of use thereof
3. 7015237 - Pyridine matrix metalloproteinase inhibitors
4. 6995151 - Isophthalic acid derivatives as matrix metalloproteinase inhibitors
5. 6881743 - Pyridine matrix metalloproteinase inhibitors
6. 6858739 - Indole and benzimidazole 15-lipoxygenase inhibitors
7. 6548499 - Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
8. 6534521 - 2-phenyl benzimidazole derivatives as MCP-1 antagonists
9. 6528528 - Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10. 6458806 - Aryl alkenamides derivatives as MCP-1 antagonists
11. 6458781 - Substituted diarylalkyl amides as calcium channel antagonists
12. 6423689 - Peptidyl calcium channel blockers
13. 6348487 - 2-phenyl benzimidazole derivatives as MCP-1 antagonists
14. 6268387 - Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
15. 6211209 - Method of inhibiting connective tissue degradation